BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26610680)

  • 1. [Functional MR imaging of the liver].
    Wibmer A; Nolz R; Trauner M; Ba-Ssalamah A
    Radiologe; 2015 Dec; 55(12):1057-66. PubMed ID: 26610680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modern magnetic resonance imaging of the liver].
    Hedderich DM; Weiss K; Maintz D; Persigehl T
    Radiologe; 2015 Dec; 55(12):1045-56. PubMed ID: 26628259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fat and iron quantification in the liver: past, present, and future.
    Yokoo T; Browning JD
    Top Magn Reson Imaging; 2014 Apr; 23(2):73-94. PubMed ID: 24690618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective staging of fibrosis by the selected texture features of liver: Which one is better, CT or MR imaging?
    Zhang X; Gao X; Liu BJ; Ma K; Yan W; Liling L; Yuhong H; Fujita H
    Comput Med Imaging Graph; 2015 Dec; 46 Pt 2():227-36. PubMed ID: 26455963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?
    Ba-Ssalamah A; Bastati N; Wibmer A; Fragner R; Hodge JC; Trauner M; Herold CJ; Bashir MR; Van Beers BE
    J Magn Reson Imaging; 2017 Mar; 45(3):646-659. PubMed ID: 27862590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions.
    Do RK; Rusinek H; Taouli B
    Magn Reson Imaging Clin N Am; 2009 May; 17(2):339-49. PubMed ID: 19406362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of the liver: how I do it.
    Semelka RC; Martin DR; Balci NC
    J Gastroenterol Hepatol; 2006 Apr; 21(4):632-7. PubMed ID: 16677146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].
    Stroszczynski C; Gaffke G; Gnauck M; Streitparth F; Wieners G; Lopez-Häninnen E
    Radiologe; 2004 Dec; 44(12):1185-91. PubMed ID: 15549226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of liver fat with magnetic resonance imaging.
    Reeder SB; Sirlin CB
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):337-57, ix. PubMed ID: 21094444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modern visualization of the liver with MRT. Current trends and future perspectives].
    Zech CJ; Schoenberg SO; Herrmann KA; Dietrich O; Menzel MI; Lanz T; Wallnöfer A; Helmberger T; Reiser MF
    Radiologe; 2004 Dec; 44(12):1160-9. PubMed ID: 15549227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era.
    Unal E; Idilman IS; Karçaaltıncaba M
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):167-182. PubMed ID: 27937040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-weighted MR imaging of the liver: qualitative and quantitative comparison of SPACE MR imaging with turbo spin-echo MR imaging.
    Dohan A; Gavini JP; Placé V; Sebbag D; Vignaud A; Herbin C; Hamzi L; Boudiaf M; Soyer P
    Eur J Radiol; 2013 Nov; 82(11):e655-61. PubMed ID: 23957939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern MRI of the small bowell].
    Scharitzer M; Ba-Ssalamah A
    Radiologe; 2015 Dec; 55(12):1067-76. PubMed ID: 26561025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High spatial resolution, respiratory-gated, t1-weighted magnetic resonance imaging of the liver and the biliary tract during the hepatobiliary phase of gadoxetic Acid-enhanced magnetic resonance imaging.
    Lee ES; Lee JM; Yu MH; Shin CI; Woo HS; Joo I; Stemmer A; Han JK; Choi BI
    J Comput Assist Tomogr; 2014; 38(3):360-6. PubMed ID: 24681858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
    Ba-Ssalamah A; Happel B; Kettenbach J; Dirisamer A; Wrba F; Längle F; Schima W
    Radiologe; 2004 Dec; 44(12):1170-84. PubMed ID: 15551031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
    Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
    Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance liver MRI for monitoring patients with known or suspected chronic liver disease.
    Pozzessere C; Porter KK; Kamel IR
    Clin Radiol; 2017 Jan; 72(1):93.e7-93.e13. PubMed ID: 27687630
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.
    Cassidy FH; Yokoo T; Aganovic L; Hanna RF; Bydder M; Middleton MS; Hamilton G; Chavez AD; Schwimmer JB; Sirlin CB
    Radiographics; 2009; 29(1):231-60. PubMed ID: 19168847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast agents as a biological marker in magnetic resonance imaging of the liver: conventional and new approaches.
    Sommer WH; Sourbron S; Huppertz A; Ingrisch M; Reiser MF; Zech CJ
    Abdom Imaging; 2012 Apr; 37(2):164-79. PubMed ID: 21516381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gd-EOB-DTPA-enhanced MR imaging: prediction of hepatic fibrosis stages using liver contrast enhancement index and liver-to-spleen volumetric ratio.
    Goshima S; Kanematsu M; Watanabe H; Kondo H; Kawada H; Moriyama N; Bae KT
    J Magn Reson Imaging; 2012 Nov; 36(5):1148-53. PubMed ID: 22848019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.